Mahamaya Lifesciences Ltd (NSE: MAHALIFE), ISIN INE0U9D01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MAHALIFE last traded at ₹168.00 (+1.76%), with a 52-week range of ₹111.00 to ₹205.05 (as of 30 Jul 2026).
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.